Sponsors (4)
The bill reclaims and blocks federal funds tied to the Manhattan DA's Office to reduce federal spending and free resources for other uses, but does so at the cost of reduced local funding for programs, potential local tax/service impacts, and increased litigation risk.
Federal budget/federal taxpayers: rescinds unobligated federal balances for the Manhattan DA's Office, freeing previously appropriated funds for potential reallocation to other priorities.
Federal taxpayers: blocks future federal payments to the Manhattan DA's Office, reducing future federal expenditures related to that office.
The Manhattan DA's Office and local programs in New York City: will lose federal grant resources, likely reducing capacity for programs or services supported by those grants.
Local governments (including New York City): could face shifted financial burdens from federal repayment requirements or funding gaps, potentially forcing higher local taxes or cuts to services.
Local governments and taxpayers: Attorney General efforts to recover funds may prompt litigation, producing legal costs and uncertainty for both the Manhattan DA's Office and the federal government.
Based on analysis of 2 sections of legislative text.
Prohibits federal funding to the Manhattan DA’s Office, rescinds its unobligated federal balances, and directs the Attorney General to seek repayment of federal amounts spent after Jan 1, 2022.
Official title: To prohibit Federal funds from being awarded or otherwise made available to the Manhattan District Attorney's Office.
Introduced January 3, 2025 by Andrew S. Biggs · Last progress January 3, 2025
Prohibits any federal funds from being awarded or made available to the Manhattan District Attorney’s Office, rescinds unobligated federal balances previously allocated to that office, and directs the Attorney General to seek repayment for all amounts the office expended after January 1, 2022. It creates a federal funding ban and a repayment directive targeted specifically at that local prosecutor's office.